Prostate Cancer Daily

July 10, 2026

Videos

Peer-to-Peer Clinical Conversations

The PROTEUS Trial of Neoadjuvant and Adjuvant Apalutamide Before Radical Prostatectomy, Journal Club - Zachary Klaassen & Rashid Sayyid

Zachary Klaassen

Rashid Sayyid and Zachary Klaassen review the PROTEUS trial, of perioperative apalutamide plus ADT versus placebo plus ADT in 2,109 high-risk localized or locally advanced prostate cancer patients undergoing radical prostatectomy.

View

PAM50 Intrinsic Subtyping and Salvage Therapy Decisions After Prostatectomy - Jonathan Tward

Jonathan Tward

Jonathan Tward presents data using PAM50 molecular classifier in 130 post-prostatectomy biochemical recurrence patients receiving salvage radiation.

View

Beyond the Abstracts

Testosterone-Sparing Treatment Strategies for Biochemically Recurrent Prostate Cancer After Radical Prostatectomy - Beyond the Abstract

Stereotactic Ablative Body Radiotherapy for PSMA-PET/CT Staged, Oligometastatic Prostate Cancer - A Multi-Centre Study - Beyond the Abstract

Conference Coverage

SNMMI 2026: Predicting Early PSA Response to 177Lu-PSMA Therapy using Baseline PET Imaging Biomarkers and Cycle 1 Dosimetry

ASCO 2026: ctDNA-Based Clinical-Genetic Prognostic Model for rPFS in Patients with mCRPC: Analysis of Alliance A031201

APCCC 2026: In Which Patients Is Metastases Directed Therapy Without Systemic Therapy Sufficient?

APCCC 2026: Debate: Patients with High-Risk Localized Prostate Cancer Need the Addition of an ARPI to Radiotherapy + Long-Term ADT – Against the Addition of ARPI to Radiotherapy + ADT

EAU 2026: Update on High-risk Non-metastatic Hormone-sensitive Prostate Cancer

Articles

Editor Selected Abstracts and Commentaries

Prostate Cancer

Outcomes of Neoadjuvant Radiotherapy Followed by Robotic Radical Prostatectomy in High-Risk Locally Advanced Prostate Cancer: A Prospective Pilot Study.

Enzalutamide in biochemically recurrent prostate cancer: clinical implications from EMBARK for real-world practice.

ProBIOPSY: A Multidisciplinary International Consensus on Standards for Prostate Biopsy.

Diabetes Is an Independent Risk Factor for Radiation-Induced Hematuria After Robotic Stereotactic Body Radiotherapy for Prostate Cancer.

Effectiveness of Enhanced Recovery After Surgery Protocols for Robot Assisted Radical Prostatectomy Radical Prostatectomy: A Systematic Review and Meta-Analysis.

Intrafraction Motion Mitigation by Rectal Spacers in Prostate SBRT: Balloon, Hydrogel, and No-Spacer Comparison - Beyond the Abstract

Blue Earth Therapeutics Announces First Participant Dosed in Phase 1 Clinical Trial Investigating Actinium (²²⁵Ac) rhPSMA-10.1 Injection in Metastatic Castration-Resistant Prostate Cancer

CONNECT WITH US

Questions or Comments? Email us at editors@urotoday.com

Digital Science Press, LLC
2011 Phaethon Lane,
Reno, NV 89523

You are receiving this email because you have chosen to receive emails from UroToday.

Prostate Cancer Daily

Prostate Cancer

Login